{"created":"2023-07-25T10:24:48.919345+00:00","id":4882,"links":{},"metadata":{"_buckets":{"deposit":"ee21f4ea-0f79-4bc3-a295-d44602b81756"},"_deposit":{"created_by":19,"id":"4882","owners":[19],"pid":{"revision_id":0,"type":"depid","value":"4882"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:00004882","sets":["611:968:969:1218"]},"author_link":["14265"],"item_10006_alternative_title_32":{"attribute_name":"別タイトル","attribute_value_mlt":[{"subitem_alternative_title":"レゴラフェニブとその代謝産物M5 の血中濃度モニタリングを用いた治療効果と皮膚毒性の予測"}]},"item_10006_biblio_info_34":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2020-03-24","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{}]}]},"item_10006_date_granted_41":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2020-03-24"}]},"item_10006_degree_grantor_40":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"秋田大学"}]}]},"item_10006_degree_name_39":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）"}]},"item_10006_dissertation_number_42":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"11401甲第1342号"}]},"item_10006_publisher_28":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"秋田大学"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"田口, 大樹"}],"nameIdentifiers":[{"nameIdentifier":"14265","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-11-19"}],"displaytype":"detail","filename":"ihakuyoushikou1342.pdf","filesize":[{"value":"683.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"内容要旨及び審査結果要旨","url":"https://air.repo.nii.ac.jp/record/4882/files/ihakuyoushikou1342.pdf"},"version_id":"69f51241-de84-46f2-8a33-00edc90cfd58"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities."}]},"item_type_id":"10006","owner":"19","path":["1218"],"pubdate":{"attribute_name":"公開日","attribute_value":"2020-11-19"},"publish_date":"2020-11-19","publish_status":"0","recid":"4882","relation_version_is_last":true,"title":["Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities."],"weko_creator_id":"19","weko_shared_id":-1},"updated":"2023-07-25T10:59:56.403492+00:00"}